Wert Lawrence's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Aug 15, 2022
- Accession no.
- 0001493152-22-022609
- Filed
- Aug 15, 2022, 8:30 AM ET
- Trade date
- Aug 11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.96K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wert LawrenceCIK 0001626623 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $0.129 | +$645 | 1,312,868 | Direct | |
| Aug 11, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $0.128 | +$640 | 1,317,868 | Direct | |
| Aug 11, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $0.135 | +$675 | 1,322,868 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.